nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezogabine—CYP2A6—Pilocarpine—glaucoma	0.286	1	CbGbCtD
Ezogabine—UGT1A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.00297	0.03	CbGpPWpGaD
Ezogabine—UGT1A3—Estrogen metabolism—CYP1B1—glaucoma	0.00279	0.0282	CbGpPWpGaD
Ezogabine—UGT1A3—Estrogen metabolism—GSTM1—glaucoma	0.00223	0.0226	CbGpPWpGaD
Ezogabine—KCNQ5—Neuronal System—SLC6A13—glaucoma	0.00212	0.0215	CbGpPWpGaD
Ezogabine—KCNQ4—Neuronal System—SLC6A13—glaucoma	0.00212	0.0215	CbGpPWpGaD
Ezogabine—NAT2—Phase II conjugation—GSTT1—glaucoma	0.00195	0.0198	CbGpPWpGaD
Ezogabine—UGT1A1—Estrogen metabolism—CYP1B1—glaucoma	0.00193	0.0195	CbGpPWpGaD
Ezogabine—UGT1A9—Estrogen metabolism—CYP1B1—glaucoma	0.00193	0.0195	CbGpPWpGaD
Ezogabine—UGT1A4—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.00158	0.016	CbGpPWpGaD
Ezogabine—KCNQ5—Neuronal System—SLC6A1—glaucoma	0.00155	0.0157	CbGpPWpGaD
Ezogabine—KCNQ4—Neuronal System—SLC6A1—glaucoma	0.00155	0.0157	CbGpPWpGaD
Ezogabine—UGT1A1—Estrogen metabolism—GSTM1—glaucoma	0.00154	0.0156	CbGpPWpGaD
Ezogabine—UGT1A9—Estrogen metabolism—GSTM1—glaucoma	0.00154	0.0156	CbGpPWpGaD
Ezogabine—UGT1A3—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.00132	0.0133	CbGpPWpGaD
Ezogabine—CYP2A6—Tamoxifen metabolism—CYP1B1—glaucoma	0.00131	0.0133	CbGpPWpGaD
Ezogabine—Dizziness—Carbachol—glaucoma	0.00125	0.00203	CcSEcCtD
Ezogabine—Vertigo—Dorzolamide—glaucoma	0.00124	0.00202	CcSEcCtD
Ezogabine—Malaise—Travoprost—glaucoma	0.00124	0.00202	CcSEcCtD
Ezogabine—Confusional state—Acetazolamide—glaucoma	0.00124	0.00202	CcSEcCtD
Ezogabine—NAT2—Phase II conjugation—GSTM1—glaucoma	0.00124	0.0126	CbGpPWpGaD
Ezogabine—Syncope—Dorzolamide—glaucoma	0.00124	0.00202	CcSEcCtD
Ezogabine—Vertigo—Travoprost—glaucoma	0.00124	0.00202	CcSEcCtD
Ezogabine—UGT1A4—NRF2 pathway—SLC6A13—glaucoma	0.00124	0.0125	CbGpPWpGaD
Ezogabine—Paraesthesia—Apraclonidine—glaucoma	0.00124	0.00201	CcSEcCtD
Ezogabine—Osteoarthritis—Timolol—glaucoma	0.00123	0.00201	CcSEcCtD
Ezogabine—Diplopia—Timolol—glaucoma	0.00123	0.00201	CcSEcCtD
Ezogabine—Vision blurred—Pilocarpine—glaucoma	0.00123	0.00201	CcSEcCtD
Ezogabine—Anxiety—Brimonidine—glaucoma	0.00123	0.002	CcSEcCtD
Ezogabine—Dizziness—Levobunolol—glaucoma	0.00123	0.002	CcSEcCtD
Ezogabine—Dyspnoea—Apraclonidine—glaucoma	0.00123	0.002	CcSEcCtD
Ezogabine—Malaise—Brinzolamide—glaucoma	0.00123	0.002	CcSEcCtD
Ezogabine—Tremor—Pilocarpine—glaucoma	0.00123	0.00199	CcSEcCtD
Ezogabine—Somnolence—Apraclonidine—glaucoma	0.00123	0.00199	CcSEcCtD
Ezogabine—Vertigo—Brinzolamide—glaucoma	0.00122	0.00199	CcSEcCtD
Ezogabine—Dysuria—Betaxolol—glaucoma	0.00122	0.00199	CcSEcCtD
Ezogabine—Rash—Diclofenamide—glaucoma	0.00122	0.00198	CcSEcCtD
Ezogabine—Discomfort—Brimonidine—glaucoma	0.00122	0.00198	CcSEcCtD
Ezogabine—Loss of consciousness—Dorzolamide—glaucoma	0.00122	0.00198	CcSEcCtD
Ezogabine—Shock—Acetazolamide—glaucoma	0.00121	0.00197	CcSEcCtD
Ezogabine—Dry mouth—Brimonidine—glaucoma	0.00121	0.00196	CcSEcCtD
Ezogabine—Thrombocytopenia—Acetazolamide—glaucoma	0.00121	0.00196	CcSEcCtD
Ezogabine—Hallucination—Clonidine—glaucoma	0.00119	0.00194	CcSEcCtD
Ezogabine—Dyspnoea—Bimatoprost—glaucoma	0.00119	0.00194	CcSEcCtD
Ezogabine—Rash—Carbachol—glaucoma	0.00119	0.00194	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Apraclonidine—glaucoma	0.00119	0.00194	CcSEcCtD
Ezogabine—Dermatitis—Carbachol—glaucoma	0.00119	0.00193	CcSEcCtD
Ezogabine—Fatigue—Apraclonidine—glaucoma	0.00119	0.00193	CcSEcCtD
Ezogabine—Weight increased—Betaxolol—glaucoma	0.00119	0.00193	CcSEcCtD
Ezogabine—Somnolence—Bimatoprost—glaucoma	0.00119	0.00193	CcSEcCtD
Ezogabine—UGT1A4—Phase II conjugation—GSTT1—glaucoma	0.00118	0.012	CbGpPWpGaD
Ezogabine—Constipation—Apraclonidine—glaucoma	0.00118	0.00192	CcSEcCtD
Ezogabine—Dyspepsia—Bimatoprost—glaucoma	0.00118	0.00191	CcSEcCtD
Ezogabine—Infection—Brimonidine—glaucoma	0.00118	0.00191	CcSEcCtD
Ezogabine—Anxiety—Dorzolamide—glaucoma	0.00118	0.00191	CcSEcCtD
Ezogabine—Syncope—Pilocarpine—glaucoma	0.00117	0.00191	CcSEcCtD
Ezogabine—Leukopenia—Pilocarpine—glaucoma	0.00117	0.00191	CcSEcCtD
Ezogabine—Anxiety—Travoprost—glaucoma	0.00117	0.0019	CcSEcCtD
Ezogabine—Nausea—Carteolol—glaucoma	0.00117	0.0019	CcSEcCtD
Ezogabine—Discomfort—Dorzolamide—glaucoma	0.00117	0.00189	CcSEcCtD
Ezogabine—Shock—Brimonidine—glaucoma	0.00116	0.00189	CcSEcCtD
Ezogabine—Infestation NOS—Betaxolol—glaucoma	0.00116	0.00189	CcSEcCtD
Ezogabine—Infestation—Betaxolol—glaucoma	0.00116	0.00189	CcSEcCtD
Ezogabine—Nervous system disorder—Brimonidine—glaucoma	0.00116	0.00189	CcSEcCtD
Ezogabine—Discomfort—Travoprost—glaucoma	0.00116	0.00189	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Bimatoprost—glaucoma	0.00115	0.00188	CcSEcCtD
Ezogabine—Dry mouth—Dorzolamide—glaucoma	0.00115	0.00188	CcSEcCtD
Ezogabine—Loss of consciousness—Pilocarpine—glaucoma	0.00115	0.00187	CcSEcCtD
Ezogabine—Nausea—Diclofenamide—glaucoma	0.00115	0.00187	CcSEcCtD
Ezogabine—Dry mouth—Travoprost—glaucoma	0.00115	0.00187	CcSEcCtD
Ezogabine—Discomfort—Brinzolamide—glaucoma	0.00115	0.00186	CcSEcCtD
Ezogabine—KCNQ2—Neuronal System—SLC6A13—glaucoma	0.00115	0.0116	CbGpPWpGaD
Ezogabine—KCNQ3—Neuronal System—SLC6A13—glaucoma	0.00115	0.0116	CbGpPWpGaD
Ezogabine—NAT2—Biological oxidations—GSTT1—glaucoma	0.00114	0.0116	CbGpPWpGaD
Ezogabine—Dizziness—Latanoprost—glaucoma	0.00114	0.00185	CcSEcCtD
Ezogabine—Confusional state—Dorzolamide—glaucoma	0.00114	0.00185	CcSEcCtD
Ezogabine—Liver function test abnormal—Timolol—glaucoma	0.00114	0.00185	CcSEcCtD
Ezogabine—Feeling abnormal—Apraclonidine—glaucoma	0.00114	0.00185	CcSEcCtD
Ezogabine—Dry mouth—Brinzolamide—glaucoma	0.00113	0.00184	CcSEcCtD
Ezogabine—Rash—Methazolamide—glaucoma	0.00112	0.00183	CcSEcCtD
Ezogabine—Dermatitis—Methazolamide—glaucoma	0.00112	0.00183	CcSEcCtD
Ezogabine—Eye disorder—Clonidine—glaucoma	0.00112	0.00182	CcSEcCtD
Ezogabine—Nausea—Carbachol—glaucoma	0.00112	0.00182	CcSEcCtD
Ezogabine—Infection—Travoprost—glaucoma	0.00112	0.00182	CcSEcCtD
Ezogabine—Shock—Dorzolamide—glaucoma	0.00111	0.00181	CcSEcCtD
Ezogabine—Anxiety—Pilocarpine—glaucoma	0.00111	0.00181	CcSEcCtD
Ezogabine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—glaucoma	0.00111	0.0112	CbGpPWpGaD
Ezogabine—Paraesthesia—Acetazolamide—glaucoma	0.00111	0.0018	CcSEcCtD
Ezogabine—Nausea—Levobunolol—glaucoma	0.00111	0.0018	CcSEcCtD
Ezogabine—Infection—Brinzolamide—glaucoma	0.0011	0.0018	CcSEcCtD
Ezogabine—Nervous system disorder—Travoprost—glaucoma	0.0011	0.0018	CcSEcCtD
Ezogabine—Discomfort—Pilocarpine—glaucoma	0.0011	0.00179	CcSEcCtD
Ezogabine—Somnolence—Acetazolamide—glaucoma	0.0011	0.00178	CcSEcCtD
Ezogabine—Hyperhidrosis—Dorzolamide—glaucoma	0.00109	0.00178	CcSEcCtD
Ezogabine—Nervous system disorder—Brinzolamide—glaucoma	0.00109	0.00177	CcSEcCtD
Ezogabine—Rash—Latanoprost—glaucoma	0.00109	0.00177	CcSEcCtD
Ezogabine—Dermatitis—Latanoprost—glaucoma	0.00109	0.00177	CcSEcCtD
Ezogabine—Dyspepsia—Acetazolamide—glaucoma	0.00109	0.00177	CcSEcCtD
Ezogabine—Confusional state—Pilocarpine—glaucoma	0.00108	0.00175	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Acetazolamide—glaucoma	0.00107	0.00173	CcSEcCtD
Ezogabine—Fatigue—Acetazolamide—glaucoma	0.00106	0.00173	CcSEcCtD
Ezogabine—Paraesthesia—Brimonidine—glaucoma	0.00106	0.00173	CcSEcCtD
Ezogabine—Infection—Pilocarpine—glaucoma	0.00106	0.00173	CcSEcCtD
Ezogabine—Alopecia—Clonidine—glaucoma	0.00106	0.00173	CcSEcCtD
Ezogabine—Nausea—Methazolamide—glaucoma	0.00106	0.00172	CcSEcCtD
Ezogabine—Dyspnoea—Brimonidine—glaucoma	0.00106	0.00172	CcSEcCtD
Ezogabine—Somnolence—Brimonidine—glaucoma	0.00105	0.00171	CcSEcCtD
Ezogabine—Mental disorder—Clonidine—glaucoma	0.00105	0.00171	CcSEcCtD
Ezogabine—Shock—Pilocarpine—glaucoma	0.00105	0.00171	CcSEcCtD
Ezogabine—Thrombocytopenia—Pilocarpine—glaucoma	0.00105	0.0017	CcSEcCtD
Ezogabine—Dyspepsia—Brimonidine—glaucoma	0.00104	0.00169	CcSEcCtD
Ezogabine—Hallucination—Betaxolol—glaucoma	0.00104	0.00169	CcSEcCtD
Ezogabine—Hyperhidrosis—Pilocarpine—glaucoma	0.00103	0.00168	CcSEcCtD
Ezogabine—UGT1A3—NRF2 pathway—SLC6A13—glaucoma	0.00103	0.0104	CbGpPWpGaD
Ezogabine—Gastrointestinal disorder—Brimonidine—glaucoma	0.00102	0.00166	CcSEcCtD
Ezogabine—Fatigue—Brimonidine—glaucoma	0.00102	0.00166	CcSEcCtD
Ezogabine—UGT1A4—NRF2 pathway—TXN—glaucoma	0.00102	0.0103	CbGpPWpGaD
Ezogabine—Feeling abnormal—Acetazolamide—glaucoma	0.00102	0.00165	CcSEcCtD
Ezogabine—Paraesthesia—Dorzolamide—glaucoma	0.00102	0.00165	CcSEcCtD
Ezogabine—Dyspnoea—Dorzolamide—glaucoma	0.00101	0.00164	CcSEcCtD
Ezogabine—Visual impairment—Betaxolol—glaucoma	0.00101	0.00164	CcSEcCtD
Ezogabine—Somnolence—Dorzolamide—glaucoma	0.00101	0.00163	CcSEcCtD
Ezogabine—Muscle spasms—Clonidine—glaucoma	0.00101	0.00163	CcSEcCtD
Ezogabine—Dyspnoea—Travoprost—glaucoma	0.001	0.00163	CcSEcCtD
Ezogabine—Paraesthesia—Brinzolamide—glaucoma	0.000998	0.00162	CcSEcCtD
Ezogabine—Dysuria—Timolol—glaucoma	0.000998	0.00162	CcSEcCtD
Ezogabine—Dyspepsia—Dorzolamide—glaucoma	0.000995	0.00162	CcSEcCtD
Ezogabine—Dyspnoea—Brinzolamide—glaucoma	0.000991	0.00161	CcSEcCtD
Ezogabine—Dyspepsia—Travoprost—glaucoma	0.000991	0.00161	CcSEcCtD
Ezogabine—Asthenia—Apraclonidine—glaucoma	0.00099	0.00161	CcSEcCtD
Ezogabine—Somnolence—Brinzolamide—glaucoma	0.000988	0.00161	CcSEcCtD
Ezogabine—Vision blurred—Clonidine—glaucoma	0.000985	0.0016	CcSEcCtD
Ezogabine—UGT1A3—Phase II conjugation—GSTT1—glaucoma	0.000983	0.00995	CbGpPWpGaD
Ezogabine—Tremor—Clonidine—glaucoma	0.00098	0.00159	CcSEcCtD
Ezogabine—Dyspepsia—Brinzolamide—glaucoma	0.000979	0.00159	CcSEcCtD
Ezogabine—Eye disorder—Betaxolol—glaucoma	0.000977	0.00159	CcSEcCtD
Ezogabine—Fatigue—Dorzolamide—glaucoma	0.000975	0.00158	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Travoprost—glaucoma	0.000972	0.00158	CcSEcCtD
Ezogabine—Fatigue—Travoprost—glaucoma	0.000971	0.00158	CcSEcCtD
Ezogabine—Ill-defined disorder—Clonidine—glaucoma	0.00097	0.00158	CcSEcCtD
Ezogabine—Constipation—Travoprost—glaucoma	0.000963	0.00157	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Brinzolamide—glaucoma	0.00096	0.00156	CcSEcCtD
Ezogabine—Paraesthesia—Pilocarpine—glaucoma	0.000959	0.00156	CcSEcCtD
Ezogabine—Asthenia—Bimatoprost—glaucoma	0.000959	0.00156	CcSEcCtD
Ezogabine—Fatigue—Brinzolamide—glaucoma	0.000958	0.00156	CcSEcCtD
Ezogabine—Dyspnoea—Pilocarpine—glaucoma	0.000953	0.00155	CcSEcCtD
Ezogabine—KCNQ2—Axon guidance—NCK2—glaucoma	0.000951	0.00962	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—NCK2—glaucoma	0.000951	0.00962	CbGpPWpGaD
Ezogabine—Somnolence—Pilocarpine—glaucoma	0.00095	0.00154	CcSEcCtD
Ezogabine—Malaise—Clonidine—glaucoma	0.000943	0.00153	CcSEcCtD
Ezogabine—Dyspepsia—Pilocarpine—glaucoma	0.000941	0.00153	CcSEcCtD
Ezogabine—Syncope—Clonidine—glaucoma	0.000938	0.00152	CcSEcCtD
Ezogabine—Feeling abnormal—Dorzolamide—glaucoma	0.000932	0.00151	CcSEcCtD
Ezogabine—Feeling abnormal—Travoprost—glaucoma	0.000928	0.00151	CcSEcCtD
Ezogabine—Alopecia—Betaxolol—glaucoma	0.000924	0.0015	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000922	0.0015	CcSEcCtD
Ezogabine—Loss of consciousness—Clonidine—glaucoma	0.000919	0.00149	CcSEcCtD
Ezogabine—Feeling abnormal—Brinzolamide—glaucoma	0.000916	0.00149	CcSEcCtD
Ezogabine—Mental disorder—Betaxolol—glaucoma	0.000916	0.00149	CcSEcCtD
Ezogabine—Constipation—Pilocarpine—glaucoma	0.000914	0.00149	CcSEcCtD
Ezogabine—Dizziness—Apraclonidine—glaucoma	0.000912	0.00148	CcSEcCtD
Ezogabine—Malnutrition—Betaxolol—glaucoma	0.00091	0.00148	CcSEcCtD
Ezogabine—NAT2—Biological oxidations—CYP1B1—glaucoma	0.00091	0.00921	CbGpPWpGaD
Ezogabine—UGT1A1—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.00091	0.0092	CbGpPWpGaD
Ezogabine—UGT1A9—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.00091	0.0092	CbGpPWpGaD
Ezogabine—UGT1A4—NRF2 pathway—SLC6A1—glaucoma	0.000907	0.00918	CbGpPWpGaD
Ezogabine—NAT2—Metapathway biotransformation—CYP1B1—glaucoma	0.000898	0.00908	CbGpPWpGaD
Ezogabine—Anxiety—Clonidine—glaucoma	0.000887	0.00144	CcSEcCtD
Ezogabine—Asthenia—Acetazolamide—glaucoma	0.000885	0.00144	CcSEcCtD
Ezogabine—Dizziness—Bimatoprost—glaucoma	0.000884	0.00144	CcSEcCtD
Ezogabine—Feeling abnormal—Pilocarpine—glaucoma	0.00088	0.00143	CcSEcCtD
Ezogabine—Discomfort—Clonidine—glaucoma	0.000879	0.00143	CcSEcCtD
Ezogabine—Muscle spasms—Betaxolol—glaucoma	0.000875	0.00142	CcSEcCtD
Ezogabine—Dry mouth—Clonidine—glaucoma	0.00087	0.00142	CcSEcCtD
Ezogabine—Dermatitis—Apraclonidine—glaucoma	0.000869	0.00141	CcSEcCtD
Ezogabine—Confusional state—Clonidine—glaucoma	0.00086	0.0014	CcSEcCtD
Ezogabine—Vision blurred—Betaxolol—glaucoma	0.000858	0.00139	CcSEcCtD
Ezogabine—Tremor—Betaxolol—glaucoma	0.000853	0.00139	CcSEcCtD
Ezogabine—Hallucination—Timolol—glaucoma	0.00085	0.00138	CcSEcCtD
Ezogabine—Asthenia—Brimonidine—glaucoma	0.00085	0.00138	CcSEcCtD
Ezogabine—Infection—Clonidine—glaucoma	0.000848	0.00138	CcSEcCtD
Ezogabine—UGT1A3—NRF2 pathway—TXN—glaucoma	0.000846	0.00856	CbGpPWpGaD
Ezogabine—Ill-defined disorder—Betaxolol—glaucoma	0.000845	0.00137	CcSEcCtD
Ezogabine—Rash—Bimatoprost—glaucoma	0.000843	0.00137	CcSEcCtD
Ezogabine—Dermatitis—Bimatoprost—glaucoma	0.000842	0.00137	CcSEcCtD
Ezogabine—Oedema peripheral—Timolol—glaucoma	0.000841	0.00137	CcSEcCtD
Ezogabine—Shock—Clonidine—glaucoma	0.000839	0.00136	CcSEcCtD
Ezogabine—KCNQ3—Neuronal System—SLC6A1—glaucoma	0.000838	0.00848	CbGpPWpGaD
Ezogabine—KCNQ2—Neuronal System—SLC6A1—glaucoma	0.000838	0.00848	CbGpPWpGaD
Ezogabine—Nervous system disorder—Clonidine—glaucoma	0.000837	0.00136	CcSEcCtD
Ezogabine—Thrombocytopenia—Clonidine—glaucoma	0.000835	0.00136	CcSEcCtD
Ezogabine—Hyperhidrosis—Clonidine—glaucoma	0.000825	0.00134	CcSEcCtD
Ezogabine—Visual impairment—Timolol—glaucoma	0.000823	0.00134	CcSEcCtD
Ezogabine—Malaise—Betaxolol—glaucoma	0.000821	0.00133	CcSEcCtD
Ezogabine—Nausea—Apraclonidine—glaucoma	0.000819	0.00133	CcSEcCtD
Ezogabine—Vertigo—Betaxolol—glaucoma	0.000818	0.00133	CcSEcCtD
Ezogabine—Syncope—Betaxolol—glaucoma	0.000816	0.00133	CcSEcCtD
Ezogabine—Dizziness—Acetazolamide—glaucoma	0.000816	0.00133	CcSEcCtD
Ezogabine—Asthenia—Dorzolamide—glaucoma	0.000811	0.00132	CcSEcCtD
Ezogabine—Asthenia—Travoprost—glaucoma	0.000808	0.00131	CcSEcCtD
Ezogabine—NAT2—Metabolism—CA5A—glaucoma	0.000801	0.0081	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—NARFL—glaucoma	0.000801	0.0081	CbGpPWpGaD
Ezogabine—Loss of consciousness—Betaxolol—glaucoma	0.0008	0.0013	CcSEcCtD
Ezogabine—Eye disorder—Timolol—glaucoma	0.000798	0.0013	CcSEcCtD
Ezogabine—Asthenia—Brinzolamide—glaucoma	0.000798	0.0013	CcSEcCtD
Ezogabine—Nausea—Bimatoprost—glaucoma	0.000794	0.00129	CcSEcCtD
Ezogabine—Dizziness—Brimonidine—glaucoma	0.000783	0.00127	CcSEcCtD
Ezogabine—Anxiety—Betaxolol—glaucoma	0.000772	0.00126	CcSEcCtD
Ezogabine—Asthenia—Pilocarpine—glaucoma	0.000767	0.00125	CcSEcCtD
Ezogabine—Paraesthesia—Clonidine—glaucoma	0.000766	0.00125	CcSEcCtD
Ezogabine—Discomfort—Betaxolol—glaucoma	0.000766	0.00124	CcSEcCtD
Ezogabine—Dyspnoea—Clonidine—glaucoma	0.000761	0.00124	CcSEcCtD
Ezogabine—Somnolence—Clonidine—glaucoma	0.000759	0.00123	CcSEcCtD
Ezogabine—Dry mouth—Betaxolol—glaucoma	0.000758	0.00123	CcSEcCtD
Ezogabine—Alopecia—Timolol—glaucoma	0.000755	0.00123	CcSEcCtD
Ezogabine—UGT1A3—NRF2 pathway—SLC6A1—glaucoma	0.000754	0.00763	CbGpPWpGaD
Ezogabine—UGT1A4—Phase II conjugation—GSTM1—glaucoma	0.000754	0.00762	CbGpPWpGaD
Ezogabine—Confusional state—Betaxolol—glaucoma	0.000749	0.00122	CcSEcCtD
Ezogabine—Mental disorder—Timolol—glaucoma	0.000748	0.00122	CcSEcCtD
Ezogabine—Dizziness—Dorzolamide—glaucoma	0.000748	0.00122	CcSEcCtD
Ezogabine—Rash—Brimonidine—glaucoma	0.000747	0.00121	CcSEcCtD
Ezogabine—Dermatitis—Brimonidine—glaucoma	0.000746	0.00121	CcSEcCtD
Ezogabine—Dizziness—Travoprost—glaucoma	0.000745	0.00121	CcSEcCtD
Ezogabine—Malnutrition—Timolol—glaucoma	0.000744	0.00121	CcSEcCtD
Ezogabine—UGT1A4—NRF2 pathway—TGFB2—glaucoma	0.000739	0.00748	CbGpPWpGaD
Ezogabine—Infection—Betaxolol—glaucoma	0.000738	0.0012	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Clonidine—glaucoma	0.000737	0.0012	CcSEcCtD
Ezogabine—Fatigue—Clonidine—glaucoma	0.000736	0.0012	CcSEcCtD
Ezogabine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—glaucoma	0.000736	0.00744	CbGpPWpGaD
Ezogabine—Dizziness—Brinzolamide—glaucoma	0.000735	0.0012	CcSEcCtD
Ezogabine—Nausea—Acetazolamide—glaucoma	0.000733	0.00119	CcSEcCtD
Ezogabine—Shock—Betaxolol—glaucoma	0.000731	0.00119	CcSEcCtD
Ezogabine—Constipation—Clonidine—glaucoma	0.00073	0.00119	CcSEcCtD
Ezogabine—Nervous system disorder—Betaxolol—glaucoma	0.000728	0.00118	CcSEcCtD
Ezogabine—NAT2—Biological oxidations—GSTM1—glaucoma	0.000728	0.00736	CbGpPWpGaD
Ezogabine—Thrombocytopenia—Betaxolol—glaucoma	0.000727	0.00118	CcSEcCtD
Ezogabine—Hyperhidrosis—Betaxolol—glaucoma	0.000718	0.00117	CcSEcCtD
Ezogabine—NAT2—Metapathway biotransformation—GSTM1—glaucoma	0.000718	0.00726	CbGpPWpGaD
Ezogabine—Rash—Dorzolamide—glaucoma	0.000713	0.00116	CcSEcCtD
Ezogabine—Dermatitis—Dorzolamide—glaucoma	0.000712	0.00116	CcSEcCtD
Ezogabine—UGT1A1—NRF2 pathway—SLC6A13—glaucoma	0.000712	0.0072	CbGpPWpGaD
Ezogabine—UGT1A9—NRF2 pathway—SLC6A13—glaucoma	0.000712	0.0072	CbGpPWpGaD
Ezogabine—Rash—Travoprost—glaucoma	0.00071	0.00115	CcSEcCtD
Ezogabine—Dermatitis—Travoprost—glaucoma	0.000709	0.00115	CcSEcCtD
Ezogabine—Dizziness—Pilocarpine—glaucoma	0.000707	0.00115	CcSEcCtD
Ezogabine—Nausea—Brimonidine—glaucoma	0.000703	0.00114	CcSEcCtD
Ezogabine—Feeling abnormal—Clonidine—glaucoma	0.000703	0.00114	CcSEcCtD
Ezogabine—Rash—Brinzolamide—glaucoma	0.000701	0.00114	CcSEcCtD
Ezogabine—Vision blurred—Timolol—glaucoma	0.000701	0.00114	CcSEcCtD
Ezogabine—Dermatitis—Brinzolamide—glaucoma	0.0007	0.00114	CcSEcCtD
Ezogabine—UGT1A4—Biological oxidations—GSTT1—glaucoma	0.000692	0.007	CbGpPWpGaD
Ezogabine—UGT1A1—Phase II conjugation—GSTT1—glaucoma	0.000679	0.00688	CbGpPWpGaD
Ezogabine—UGT1A9—Phase II conjugation—GSTT1—glaucoma	0.000679	0.00688	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—NCK2—glaucoma	0.000678	0.00686	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—NCK2—glaucoma	0.000678	0.00686	CbGpPWpGaD
Ezogabine—UGT1A4—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	0.000676	0.00684	CbGpPWpGaD
Ezogabine—Rash—Pilocarpine—glaucoma	0.000674	0.0011	CcSEcCtD
Ezogabine—Dermatitis—Pilocarpine—glaucoma	0.000673	0.00109	CcSEcCtD
Ezogabine—Nausea—Dorzolamide—glaucoma	0.000672	0.00109	CcSEcCtD
Ezogabine—Nausea—Travoprost—glaucoma	0.000669	0.00109	CcSEcCtD
Ezogabine—Vertigo—Timolol—glaucoma	0.000668	0.00109	CcSEcCtD
Ezogabine—Paraesthesia—Betaxolol—glaucoma	0.000667	0.00108	CcSEcCtD
Ezogabine—Syncope—Timolol—glaucoma	0.000667	0.00108	CcSEcCtD
Ezogabine—Dyspnoea—Betaxolol—glaucoma	0.000662	0.00108	CcSEcCtD
Ezogabine—Nausea—Brinzolamide—glaucoma	0.00066	0.00107	CcSEcCtD
Ezogabine—Dyspepsia—Betaxolol—glaucoma	0.000654	0.00106	CcSEcCtD
Ezogabine—Loss of consciousness—Timolol—glaucoma	0.000654	0.00106	CcSEcCtD
Ezogabine—CYP2A6—Fluoropyrimidine Activity—MTHFR—glaucoma	0.000646	0.00654	CbGpPWpGaD
Ezogabine—Gastrointestinal disorder—Betaxolol—glaucoma	0.000641	0.00104	CcSEcCtD
Ezogabine—Fatigue—Betaxolol—glaucoma	0.00064	0.00104	CcSEcCtD
Ezogabine—Constipation—Betaxolol—glaucoma	0.000635	0.00103	CcSEcCtD
Ezogabine—Nausea—Pilocarpine—glaucoma	0.000635	0.00103	CcSEcCtD
Ezogabine—Anxiety—Timolol—glaucoma	0.000631	0.00103	CcSEcCtD
Ezogabine—UGT1A3—Phase II conjugation—GSTM1—glaucoma	0.000626	0.00634	CbGpPWpGaD
Ezogabine—Discomfort—Timolol—glaucoma	0.000625	0.00102	CcSEcCtD
Ezogabine—Dry mouth—Timolol—glaucoma	0.000619	0.00101	CcSEcCtD
Ezogabine—UGT1A3—NRF2 pathway—TGFB2—glaucoma	0.000615	0.00622	CbGpPWpGaD
Ezogabine—Asthenia—Clonidine—glaucoma	0.000612	0.000995	CcSEcCtD
Ezogabine—Feeling abnormal—Betaxolol—glaucoma	0.000612	0.000995	CcSEcCtD
Ezogabine—Confusional state—Timolol—glaucoma	0.000612	0.000995	CcSEcCtD
Ezogabine—Infection—Timolol—glaucoma	0.000603	0.00098	CcSEcCtD
Ezogabine—Shock—Timolol—glaucoma	0.000597	0.000971	CcSEcCtD
Ezogabine—Nervous system disorder—Timolol—glaucoma	0.000595	0.000968	CcSEcCtD
Ezogabine—Hyperhidrosis—Timolol—glaucoma	0.000587	0.000954	CcSEcCtD
Ezogabine—UGT1A1—NRF2 pathway—TXN—glaucoma	0.000584	0.00591	CbGpPWpGaD
Ezogabine—UGT1A9—NRF2 pathway—TXN—glaucoma	0.000584	0.00591	CbGpPWpGaD
Ezogabine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—glaucoma	0.000579	0.00586	CbGpPWpGaD
Ezogabine—UGT1A3—Biological oxidations—GSTT1—glaucoma	0.000575	0.00582	CbGpPWpGaD
Ezogabine—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000567	0.00574	CbGpPWpGaD
Ezogabine—Dizziness—Clonidine—glaucoma	0.000564	0.000917	CcSEcCtD
Ezogabine—UGT1A3—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	0.000562	0.00569	CbGpPWpGaD
Ezogabine—CYP2A6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000559	0.00566	CbGpPWpGaD
Ezogabine—UGT1A4—Biological oxidations—CYP1B1—glaucoma	0.000551	0.00558	CbGpPWpGaD
Ezogabine—CYP2A6—NRF2 pathway—SLC6A13—glaucoma	0.000549	0.00555	CbGpPWpGaD
Ezogabine—Paraesthesia—Timolol—glaucoma	0.000545	0.000886	CcSEcCtD
Ezogabine—UGT1A4—Metapathway biotransformation—CYP1B1—glaucoma	0.000544	0.0055	CbGpPWpGaD
Ezogabine—Dyspnoea—Timolol—glaucoma	0.000541	0.00088	CcSEcCtD
Ezogabine—Somnolence—Timolol—glaucoma	0.00054	0.000877	CcSEcCtD
Ezogabine—Rash—Clonidine—glaucoma	0.000538	0.000875	CcSEcCtD
Ezogabine—Dermatitis—Clonidine—glaucoma	0.000537	0.000874	CcSEcCtD
Ezogabine—Dyspepsia—Timolol—glaucoma	0.000534	0.000868	CcSEcCtD
Ezogabine—Asthenia—Betaxolol—glaucoma	0.000533	0.000867	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Timolol—glaucoma	0.000524	0.000852	CcSEcCtD
Ezogabine—Fatigue—Timolol—glaucoma	0.000523	0.000851	CcSEcCtD
Ezogabine—UGT1A1—NRF2 pathway—SLC6A1—glaucoma	0.000521	0.00527	CbGpPWpGaD
Ezogabine—UGT1A9—NRF2 pathway—SLC6A1—glaucoma	0.000521	0.00527	CbGpPWpGaD
Ezogabine—Nausea—Clonidine—glaucoma	0.000507	0.000824	CcSEcCtD
Ezogabine—UGT1A4—NRF2 pathway—GSTM1—glaucoma	0.000503	0.00509	CbGpPWpGaD
Ezogabine—Feeling abnormal—Timolol—glaucoma	0.0005	0.000813	CcSEcCtD
Ezogabine—Dizziness—Betaxolol—glaucoma	0.000491	0.000799	CcSEcCtD
Ezogabine—UGT1A4—Metabolism—NARFL—glaucoma	0.000485	0.00491	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CA5A—glaucoma	0.000485	0.00491	CbGpPWpGaD
Ezogabine—UGT1A4—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	0.000482	0.00488	CbGpPWpGaD
Ezogabine—Rash—Betaxolol—glaucoma	0.000468	0.000761	CcSEcCtD
Ezogabine—Dermatitis—Betaxolol—glaucoma	0.000468	0.000761	CcSEcCtD
Ezogabine—CYP2A6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.00046	0.00465	CbGpPWpGaD
Ezogabine—UGT1A3—Biological oxidations—CYP1B1—glaucoma	0.000458	0.00464	CbGpPWpGaD
Ezogabine—UGT1A9—PPARA activates gene expression—ABCA1—glaucoma	0.000453	0.00458	CbGpPWpGaD
Ezogabine—UGT1A3—Metapathway biotransformation—CYP1B1—glaucoma	0.000452	0.00457	CbGpPWpGaD
Ezogabine—CYP2A6—NRF2 pathway—TXN—glaucoma	0.000451	0.00456	CbGpPWpGaD
Ezogabine—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCA1—glaucoma	0.000443	0.00448	CbGpPWpGaD
Ezogabine—Nausea—Betaxolol—glaucoma	0.000441	0.000717	CcSEcCtD
Ezogabine—UGT1A4—Biological oxidations—GSTM1—glaucoma	0.000441	0.00446	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—PAX6—glaucoma	0.000439	0.00445	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—PAX6—glaucoma	0.000439	0.00445	CbGpPWpGaD
Ezogabine—Asthenia—Timolol—glaucoma	0.000435	0.000708	CcSEcCtD
Ezogabine—UGT1A4—Metapathway biotransformation—GSTM1—glaucoma	0.000435	0.0044	CbGpPWpGaD
Ezogabine—UGT1A1—Phase II conjugation—GSTM1—glaucoma	0.000433	0.00438	CbGpPWpGaD
Ezogabine—UGT1A9—Phase II conjugation—GSTM1—glaucoma	0.000433	0.00438	CbGpPWpGaD
Ezogabine—UGT1A1—NRF2 pathway—TGFB2—glaucoma	0.000425	0.0043	CbGpPWpGaD
Ezogabine—UGT1A9—NRF2 pathway—TGFB2—glaucoma	0.000425	0.0043	CbGpPWpGaD
Ezogabine—UGT1A3—NRF2 pathway—GSTM1—glaucoma	0.000418	0.00423	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—NARFL—glaucoma	0.000403	0.00408	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CA5A—glaucoma	0.000403	0.00408	CbGpPWpGaD
Ezogabine—CYP2A6—NRF2 pathway—SLC6A1—glaucoma	0.000402	0.00406	CbGpPWpGaD
Ezogabine—Dizziness—Timolol—glaucoma	0.000401	0.000652	CcSEcCtD
Ezogabine—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	0.000401	0.00405	CbGpPWpGaD
Ezogabine—UGT1A1—Biological oxidations—GSTT1—glaucoma	0.000397	0.00402	CbGpPWpGaD
Ezogabine—UGT1A9—Biological oxidations—GSTT1—glaucoma	0.000397	0.00402	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—CA1—glaucoma	0.000391	0.00396	CbGpPWpGaD
Ezogabine—UGT1A9—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	0.000388	0.00393	CbGpPWpGaD
Ezogabine—UGT1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	0.000388	0.00393	CbGpPWpGaD
Ezogabine—Rash—Timolol—glaucoma	0.000383	0.000622	CcSEcCtD
Ezogabine—Dermatitis—Timolol—glaucoma	0.000382	0.000622	CcSEcCtD
Ezogabine—NAT2—Metabolism—CTSA—glaucoma	0.000379	0.00383	CbGpPWpGaD
Ezogabine—UGT1A3—Biological oxidations—GSTM1—glaucoma	0.000366	0.00371	CbGpPWpGaD
Ezogabine—UGT1A3—Metapathway biotransformation—GSTM1—glaucoma	0.000361	0.00366	CbGpPWpGaD
Ezogabine—Nausea—Timolol—glaucoma	0.00036	0.000586	CcSEcCtD
Ezogabine—NAT2—Metabolism—CA2—glaucoma	0.000358	0.00362	CbGpPWpGaD
Ezogabine—CYP2A6—NRF2 pathway—TGFB2—glaucoma	0.000327	0.00331	CbGpPWpGaD
Ezogabine—UGT1A1—Biological oxidations—CYP1B1—glaucoma	0.000317	0.0032	CbGpPWpGaD
Ezogabine—UGT1A9—Biological oxidations—CYP1B1—glaucoma	0.000317	0.0032	CbGpPWpGaD
Ezogabine—UGT1A1—Metapathway biotransformation—CYP1B1—glaucoma	0.000312	0.00316	CbGpPWpGaD
Ezogabine—UGT1A9—Metapathway biotransformation—CYP1B1—glaucoma	0.000312	0.00316	CbGpPWpGaD
Ezogabine—CYP2A6—Biological oxidations—GSTT1—glaucoma	0.000306	0.0031	CbGpPWpGaD
Ezogabine—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—glaucoma	0.000305	0.00309	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000296	0.00299	CbGpPWpGaD
Ezogabine—UGT1A1—NRF2 pathway—GSTM1—glaucoma	0.000289	0.00292	CbGpPWpGaD
Ezogabine—UGT1A9—NRF2 pathway—GSTM1—glaucoma	0.000289	0.00292	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—NARFL—glaucoma	0.000279	0.00282	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CA5A—glaucoma	0.000279	0.00282	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—NARFL—glaucoma	0.000279	0.00282	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CA5A—glaucoma	0.000279	0.00282	CbGpPWpGaD
Ezogabine—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	0.000277	0.0028	CbGpPWpGaD
Ezogabine—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	0.000277	0.0028	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—MMP2—glaucoma	0.000271	0.00274	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—MMP2—glaucoma	0.000271	0.00274	CbGpPWpGaD
Ezogabine—UGT1A1—Biological oxidations—GSTM1—glaucoma	0.000253	0.00256	CbGpPWpGaD
Ezogabine—UGT1A9—Biological oxidations—GSTM1—glaucoma	0.000253	0.00256	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—TXN—glaucoma	0.000252	0.00255	CbGpPWpGaD
Ezogabine—UGT1A1—Metapathway biotransformation—GSTM1—glaucoma	0.00025	0.00253	CbGpPWpGaD
Ezogabine—UGT1A9—Metapathway biotransformation—GSTM1—glaucoma	0.00025	0.00253	CbGpPWpGaD
Ezogabine—CYP2A6—Fluoropyrimidine Activity—TP53—glaucoma	0.000245	0.00248	CbGpPWpGaD
Ezogabine—CYP2A6—Biological oxidations—CYP1B1—glaucoma	0.000244	0.00247	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CA1—glaucoma	0.000237	0.0024	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CTSA—glaucoma	0.000229	0.00232	CbGpPWpGaD
Ezogabine—CYP2A6—NRF2 pathway—GSTM1—glaucoma	0.000223	0.00225	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CA2—glaucoma	0.000217	0.00219	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CA5A—glaucoma	0.000215	0.00217	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—NARFL—glaucoma	0.000215	0.00217	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—MMP9—glaucoma	0.000204	0.00206	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—MMP9—glaucoma	0.000204	0.00206	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CA1—glaucoma	0.000197	0.00199	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—GSTT1—glaucoma	0.000195	0.00198	CbGpPWpGaD
Ezogabine—CYP2A6—Biological oxidations—GSTM1—glaucoma	0.000195	0.00197	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—MMP2—glaucoma	0.000194	0.00196	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—MMP2—glaucoma	0.000194	0.00196	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CTSA—glaucoma	0.000191	0.00193	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—VEGFA—glaucoma	0.000183	0.00185	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—VEGFA—glaucoma	0.000183	0.00185	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CA2—glaucoma	0.00018	0.00182	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—CYP1B1—glaucoma	0.000156	0.00157	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ABCA1—glaucoma	0.000156	0.00157	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—TXN—glaucoma	0.000153	0.00154	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—MMP9—glaucoma	0.000145	0.00147	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—MMP9—glaucoma	0.000145	0.00147	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CA1—glaucoma	0.000136	0.00138	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CA1—glaucoma	0.000136	0.00138	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CTSA—glaucoma	0.000132	0.00133	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CTSA—glaucoma	0.000132	0.00133	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—VEGFA—glaucoma	0.000131	0.00132	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—VEGFA—glaucoma	0.000131	0.00132	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—TXN—glaucoma	0.000127	0.00128	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CA2—glaucoma	0.000124	0.00126	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CA2—glaucoma	0.000124	0.00126	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—GSTM1—glaucoma	0.000124	0.00126	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.000122	0.00123	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.000122	0.00123	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GSTT1—glaucoma	0.000118	0.0012	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—TNF—glaucoma	0.000112	0.00113	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—TNF—glaucoma	0.000112	0.00113	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—MTHFR—glaucoma	0.00011	0.00111	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CA1—glaucoma	0.000105	0.00106	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—APOE—glaucoma	0.000102	0.00104	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CTSA—glaucoma	0.000102	0.00103	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—CAV1—glaucoma	0.000101	0.00103	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GSTT1—glaucoma	9.84e-05	0.000996	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CA2—glaucoma	9.59e-05	0.000971	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ABCA1—glaucoma	9.43e-05	0.000954	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CYP1B1—glaucoma	9.43e-05	0.000954	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—TXN—glaucoma	8.77e-05	0.000887	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—TXN—glaucoma	8.77e-05	0.000887	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—APOE—glaucoma	8e-05	0.000809	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	7.93e-05	0.000802	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ABCA1—glaucoma	7.84e-05	0.000793	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CYP1B1—glaucoma	7.84e-05	0.000793	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—NOS3—glaucoma	7.67e-05	0.000776	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GSTM1—glaucoma	7.54e-05	0.000763	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PTGS2—glaucoma	7.01e-05	0.00071	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GSTT1—glaucoma	6.8e-05	0.000688	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GSTT1—glaucoma	6.8e-05	0.000688	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—TXN—glaucoma	6.76e-05	0.000684	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—MTHFR—glaucoma	6.66e-05	0.000674	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GSTM1—glaucoma	6.27e-05	0.000634	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—APOE—glaucoma	6.2e-05	0.000628	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CAV1—glaucoma	6.15e-05	0.000622	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—MTHFR—glaucoma	5.54e-05	0.00056	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	5.48e-05	0.000555	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ABCA1—glaucoma	5.42e-05	0.000548	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ABCA1—glaucoma	5.42e-05	0.000548	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP1B1—glaucoma	5.42e-05	0.000548	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP1B1—glaucoma	5.42e-05	0.000548	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GSTT1—glaucoma	5.24e-05	0.00053	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—APOE—glaucoma	5.16e-05	0.000522	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CAV1—glaucoma	5.11e-05	0.000517	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—NOS3—glaucoma	4.65e-05	0.00047	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GSTM1—glaucoma	4.33e-05	0.000438	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GSTM1—glaucoma	4.33e-05	0.000438	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PTGS2—glaucoma	4.25e-05	0.00043	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ABCA1—glaucoma	4.18e-05	0.000422	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CYP1B1—glaucoma	4.18e-05	0.000422	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—NOS3—glaucoma	3.86e-05	0.000391	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—MTHFR—glaucoma	3.83e-05	0.000387	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—MTHFR—glaucoma	3.83e-05	0.000387	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—APOE—glaucoma	3.56e-05	0.00036	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—APOE—glaucoma	3.56e-05	0.00036	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PTGS2—glaucoma	3.53e-05	0.000357	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CAV1—glaucoma	3.53e-05	0.000357	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CAV1—glaucoma	3.53e-05	0.000357	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GSTM1—glaucoma	3.34e-05	0.000338	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—MTHFR—glaucoma	2.95e-05	0.000298	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—APOE—glaucoma	2.75e-05	0.000278	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CAV1—glaucoma	2.72e-05	0.000275	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—NOS3—glaucoma	2.67e-05	0.00027	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—NOS3—glaucoma	2.67e-05	0.00027	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PTGS2—glaucoma	2.44e-05	0.000247	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PTGS2—glaucoma	2.44e-05	0.000247	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—NOS3—glaucoma	2.06e-05	0.000208	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PTGS2—glaucoma	1.88e-05	0.00019	CbGpPWpGaD
